October 25, 2016

Diplomat Pharmacy on Tuesday announced that, in honor of American Pharmacists Month, it would be hosting a Diplomat Dialogue series that would take a closer look at the role of pharmacists.

October 21, 2016

Endo SVP global finance operations Blaise Coleman will serve as interim CFO, and Endo said it would begin a search for a permanent replacement for Upadhyay. 

October 21, 2016

Thrifty White offers its specialty patients full pharmacy support services and has expanded its capabilities to serve specialty patients in all 50 states, in addition to the specialty medication pickup it offers at 90 of its retail locations. 

October 19, 2016

Camber Pharmaceuticals announced Wednesday that its parent company, Hetero Drugs, has been recognized by Gilead Sciences for its work providing access to hepatitis C drugs for patients worldwide.

October 19, 2016

The report, compiled on behalf of the Generic Pharmaceutical Association, found that in 2015, generic drugs brought patients and the U.S. healthcare system 227 billion in savings, bringing the savings since 2005 from generics to $1.46 trillion. 

October 19, 2016

Drug Store News recently spoke with Walgreens Specialty Pharmacy group VP Gerry Gleeson about the company’s approach to specialty and the importance of a focus on patient care and pharmacist education in that space.

October 18, 2016
Inflectra will be the second biosimilar available in the United States, and the first biosimilar monoclonal antibody. 
October 17, 2016

Specialty medicines made up 36% of all drug spend for the year ended May 2016, according to IMS Health data.

October 11, 2016

Diplomat Pharmacy on Tuesday announced that it is celebrating specialty pharmacists during American Pharmacists Month with a campaign aimed at exploring the role of pharmacists working in specialty. 

October 6, 2016
Under the agreement, Lupin would develop multiple pediatric products using Monosol Rx’s PharmFilm drug delivery technology. 
October 6, 2016

Teva and Celltrion on Thursday announced a new exclusive partnership centered on commercializing two of Celltrion’s biosimilar candidates in the United States and Canada. 

September 28, 2016

Thrifty White recently expanded its capabilities to service specialty patients in all 50 states, and it offers specialty medication pickup at 90 retail locations.

September 27, 2016

BioPlus Specialty Pharmacy announced Tuesday that it had received accreditation from the Accreditation Commission for Health Care (ACHC) with a distinction in oncology. 

September 27, 2016

Walgreens will offer its specialty pharmacists on-demand and live education courses on many of the most prevalent specialty pharmacy-managed disease states, including oncology, fertility, hepatitis C, cystic fibrosis, multiple sclerosis and chronic inflammatory/autoimmune diseases. 

September 26, 2016

Amjevita is the fourth approved biosimilar in the United States, and Amgen’s first approved biosimilar. 

September 26, 2016

Janssen Biotech announced Monday that the Food and Drug Administration had approved its Stelara (ustekinumab) to treat moderately to severely active Crohn’s disease.  

September 26, 2016

Pfizer announced Monday that its board of directors and executive leadership team had decided not to split the company into two separate companies, Pfizer Innovative Health and Pfizer Essential Health. The two will remain separately managed units within Pfizer. 

September 21, 2016

Allergan will be acquiring Akarna Therapeutics and its portfolio of developing treatments for an upfront payment of $50 million plus potential clinical, regulatory and commercial milestone payments around its lead compound AKN-083. 

September 21, 2016

The Pharmaceutical Research and Manufacturers of America (PhRMA) on Wednesday brought 60 of its member companies’ researchers to Capitol Hill for meetings with members of Congress.

September 20, 2016

Allergan has announced an acquisition aimed at making it a leader in the development of treatment for nonalcoholic steatohepatitis (NASH), a disease state seeing increased interest from drug makers. 

September 20, 2016
BioPharmaDIVE is reporting on a recently filed lawsuit from Sanofi contending that Merck & Co. infringed on its patents for Lantus (uinsulin glargine) and its insulin delivery device soloSTAR. The lawsuit follows Merck’s announcement that it had filed a New Drug Application with the Food and Drug Administration for follow-on biologic insulin glargine product. It has previously sued Eli Lilly & Co., alleging that its insulin biosimilar infringed on its patents, which delayed the launch of Lilly’s Basalgar until December. (BioPharmaDIVE)
 

 

September 19, 2016

Both the Pharmaceutical Research and Manufacturers of America and the Biotechnology Innovation Organization issues statements in support of the letter.

September 13, 2016
The partnership between KloudScript and Illinois independent Doc’s Pharmacy allows for patient access to specialty pharmacy treatments at retail as an alternative to mail-order specialty pharmacies. 
 
September 12, 2016

“We are excited to welcome Excelera members into NASP and important conversations around appropriate access to specialty medications and related services,” NASP membership committee chair Mike Agostino said